Enterprise strength
Brand competitiveness
Safety
Regeneration






Technology
Team
Environmentally
Friendly and original




Derivative
Expert team

Liu Wanshun
Academic Leader
Professor and doctoral supervisor of the School of Marine Life, Ocean University of China. He has been engaged in the research and development of chitosan for nearly 40 years. He is the founder of the chitosan industry, the leader of the research on modified chitosan and its industrialization, and the leader of the development of the marine biomedical material industry. He has won 25 national invention patents and won the national The third prize for invention, the second prize for national scientific and technological progress, the second prize for scientific and technological progress of the Ministry of Education, the first prize for scientific and technological progress of the State Oceanic Administration, the second prize for invention of Shandong Province, and the Chinese Patent Excellence Award, etc. 10 items.

Wang Yunbing
Consultant and Expert
Professor Wang Yunbing, Director of the National Biomedical Materials Engineering Technology Research Center, Vice Chairman of the Chinese Society of Biomaterials, and a national high-level talent. Professor Wang Yunbing was the chief technical director and inventor of the world's first approved Abbott polylactic acid fully degradable polymer stent. Seeing the performance and characteristics of chitosan-based fully degradable vascular stents, he established the only national biomedical stent. The material innovation research base conducts cooperative research and development of this key project.

Xi Yanfei
Consultant and Expert
北Director of the Center for Biomedical Materials and Tissue Engineering, Institute of Frontier Interdisciplinary Studies, Peking University. The former director of the Central Inspection Institute of the Central Inspection Institute.The company is developing and has successfully developed innovative medical device products. Together with Director Xi, the establishment and improvement of medical device biological evaluation standards and test methods are carried out.

Liu Liangming
Consultant and Expert
Director of the Second Research Office, Institute of Field Surgery, Daping HospitalCarry out cooperative research and development of new tactical war wounded treatment materials
Key achievements
Shuyi Yarn
National Eleventh Five-Year 863 Key Project Landed Products
hemostatic guaiac
In 2020, obtained the CE certification of EU Class III medical devices
trauma first aid hemostatic granules
National Twelfth Five-Year 863 Project Landed Products
Cooperative partner







品牌竞争力

安全再生

科技团队

环保独创

衍生
专家团队

Liu Wanshun
Academic Leader
Professor and doctoral supervisor of the School of Marine Life, Ocean University of China. He has been engaged in the research and development of chitosan for nearly 40 years. He is the founder of the chitosan industry, the leader of the research on modified chitosan and its industrialization, and the leader of the development of the marine biomedical material industry. He has won 25 national invention patents and won the national The third prize for invention, the second prize for national scientific and technological progress, the second prize for scientific and technological progress of the Ministry of Education, the first prize for scientific and technological progress of the State Oceanic Administration, the second prize for invention of Shandong Province, and the Chinese Patent Excellence Award, etc. 10 items.

Wang Yunbing
Consultant and Expert
Professor Wang Yunbing, Director of the National Biomedical Materials Engineering Technology Research Center, Vice Chairman of the Chinese Society of Biomaterials, and a national high-level talent. Professor Wang Yunbing was the chief technical director and inventor of the world's first approved Abbott polylactic acid fully degradable polymer stent. Seeing the performance and characteristics of chitosan-based fully degradable vascular stents, he established the only national biomedical stent. The material innovation research base conducts cooperative research and development of this key project.

Xi Yanfei
Consultant and Expert
北京大学前沿交叉学科研究院生物医用材料与组织工程中心主任。原中检院中检所主任。
公司正在研发和已经研发成功的均为创新型医疗器械产品,与奚主任一起进行医疗器械生物学评价标准和试验方法的建立和改进工作。

Liu Liangming
Consultant and Expert
大坪医院野战外科研究所第二研究室主任
进行新型战术战伤救治材料的合作研发工作
重点成果

术益纱
国家十一五863重点课题落地产品

止血愈创纱
2020年获得欧盟三类医疗器械CE认证

创伤急救止血颗粒
国家十二五863项目落地产
合作伙伴






